Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
The American Journal of Medicine
|
December 15, 2018
Plecanatide for Treatment of Chronic Constipation and Irritable Bowel Syndrome
Bryan L Love
The American Journal of Managed Care
|
June 9, 2016
Report: pharmacotherapy for moderate to severe inflammatory bowel disease: evolving strategies
Bryan L Love
The American Journal of Gastroenterology
|
January 24, 2023
Cost-Effectiveness of Vonoprazan-Based and Rifabutin-Based vs Other Regimens as First-Line Treatment of Helicobacter pylori Infection in the United States
Ismaeel Yunusa, Bryan L Love
The American Journal of Gastroenterology
|
May 31, 2023
Response to Almenoff
Ismaeel Yunusa, Bryan L Love
Journal of Managed Care & Specialty Pharmacy
|
June 26, 2020
Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses
T Joseph Mattingly, Bryan L Love
American Journal of Pharmaceutical Education
|
August 28, 2010
Development of a reliable, valid annual skills mastery assessment examination
Gregory L Alston, Bryan L Love
The Annals of Pharmacotherapy
|
November 2, 2012
Extended-release mesalamine granules for ulcerative colitis
Bryan L Love, April D Miller
Journal of Clinical Pharmacy and Therapeutics
|
August 4, 2009
Hypertriglyceridaemia-induced acute pancreatitis due to patient non-compliance
Bryan L Love, H Kehr, J L Olin
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
Successful treatment with ceftriaxone induction and minocycline maintenance for gastrointestinal Whipple's disease
Caroline Derrick, Bryan L Love, Kamla Sanasi-Bhola
Pharmacoeconomics
|
June 14, 2020
Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review
T Joseph Mattingly, Bryan L Love, Bilal Khokhar
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
The American Journal of Medicine
|
December 15, 2018
Plecanatide for Treatment of Chronic Constipation and Irritable Bowel Syndrome
Bryan L Love
The American Journal of Managed Care
|
June 9, 2016
Report: pharmacotherapy for moderate to severe inflammatory bowel disease: evolving strategies
Bryan L Love
The American Journal of Gastroenterology
|
January 24, 2023
Cost-Effectiveness of Vonoprazan-Based and Rifabutin-Based vs Other Regimens as First-Line Treatment of Helicobacter pylori Infection in the United States
Ismaeel Yunusa, Bryan L Love
The American Journal of Gastroenterology
|
May 31, 2023
Response to Almenoff
Ismaeel Yunusa, Bryan L Love
Journal of Managed Care & Specialty Pharmacy
|
June 26, 2020
Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses
T Joseph Mattingly, Bryan L Love
American Journal of Pharmaceutical Education
|
August 28, 2010
Development of a reliable, valid annual skills mastery assessment examination
Gregory L Alston, Bryan L Love
The Annals of Pharmacotherapy
|
November 2, 2012
Extended-release mesalamine granules for ulcerative colitis
Bryan L Love, April D Miller
Journal of Clinical Pharmacy and Therapeutics
|
August 4, 2009
Hypertriglyceridaemia-induced acute pancreatitis due to patient non-compliance
Bryan L Love, H Kehr, J L Olin
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
Successful treatment with ceftriaxone induction and minocycline maintenance for gastrointestinal Whipple's disease
Caroline Derrick, Bryan L Love, Kamla Sanasi-Bhola
Pharmacoeconomics
|
June 14, 2020
Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review
T Joseph Mattingly, Bryan L Love, Bilal Khokhar
Page
of 5